News

See the latest from Closed Loop Medicine.

Press releases

Closed Loop Medicine appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer

Press releases

Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure

Press releases

Closed Loop Medicine closes £13 million to finance its personalised drug + digital therapy (DTx) combination products to improve outcomes for patients through precision dosing.

Press releases

Closed Loop Medicine appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer

Press releases

Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure

Press releases

Closed Loop Medicine closes £13 million to finance its personalised drug + digital therapy (DTx) combination products to improve outcomes for patients through precision dosing.

View all In the media News Item Press releases
In the media

Closed Loop Medicine Wants To Deliver Upon Its Name, Tailoring Drug Dosages

Press releases

Closed Loop Medicine appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer

In the media

Closed Loop Medicine wraps DTx trial for hypertension treatment

Press releases

Closed Loop Medicine joins 28 UK HealthTech pioneers on ABHI mission to strengthen trade relations in Texas

Press releases

Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure

Press releases

Closed Loop Medicine appoints Paul Jakimciw as Chief Product Officer and Dr Myles Furnace as VP, Commercial Strategy, Partnerships and Market Access

Press releases

Closed Loop Medicine closes £13 million to finance its personalised drug + digital therapy (DTx) combination products to improve outcomes for patients through precision dosing.

Press releases

Closed Loop Medicine announces positive outcome of a key clinical drug study required for regulatory submission of its ‘drug plus digital’ insomnia product CLM-IN01.

Press releases

Closed Loop Medicine secures UKCA marking and receives CE designation for a Medical Device that will form part of its insomnia product CLM-IN01

Press releases

Closed Loop Medicine completes recruitment into clinical study that is required for regulatory submission of its insomnia product CLM-IN01

In the media

Closed Loop Medicine recruits first patient into clinical trial for patients with high blood pressure

In the media

Blood diamond: Milestone for Closed Loop Medicine in hypertension trial